Inovio MERS Vaccine Development to be Expanded with Funding from IVI

Inovio Pharmaceuticals, Inc. {NASDAQ:INO} today announced that the International Vaccine Institute (IVI) will provide new funding and support to further advance GLS-5300, Inovio’s vaccine to prevent Middle East Respiratory Syndrome (MERS) virus infection.

 

 

Inovio MERS Vaccine Development to be Expanded with Funding from International Vaccine Institute

Inovio Pharmaceuticals, Inc. {NASDAQ:INO} today announced that the International Vaccine Institute (IVI) will provide new funding and support to further advance GLS-5300, Inovio’s vaccine to prevent Middle East Respiratory Syndrome (MERS) virus infection. Inovio is co-developing this vaccine with GeneOne Life Science. IVI will add technical, laboratory and financial support for GLS-5300 clinical trials in Korea.

Inovio, GeneOne and its academic collaborators have evaluated GLS-5300 in mice, rhesus macaques and camels. As published in Science Translational Medicine, the vaccine induced robust immune responses in all three species. GLS-5300 has been specifically able to induce 100% protection from a live virus challenge in a rhesus macaque non-human primate study. The results of the non-human primate study supported the conduct of the first phase I clinical trial of 75 healthy volunteers in collaboration with the Walter Reed Army Institute of Research.

Dr. J. Joseph Kim, Inovio’s President & CEO and a member of the Board of Trustees of IVI, said, “This collaborative funding is part of a 41 billion Won (USD $34 million) grant publicly pledged in 2015 from the Samsung Foundation to IVI to support the development of a MERS vaccine for emergency use in Korea and internationally. The goal of this funding is to expand clinical testing of GLS-5300 toward emergency use authorization by the Korean government as well as authorities of other countries.”

“Inovio’s GLS-5300 remains the only vaccine for MERS in clinical testing. With this support from IVI, Inovio, GeneOne, and our other collaborators can expand GLS-5300 vaccine development in Korea and the US. Our phase I MERS trial in the U.S. is fully enrolled with 75 subjects dosed. We intend to report interim data in early 2017 and publish the full data set in peer reviewed journals. We already published positive non-human primate protection results. After obtaining human safety and immunogenicity data, we may be in position to secure additional external funding as well as approach regulators next year to discuss the path to approval via the “Animal Rule,” Dr. Kim said.

Despite the continuing threat of MERS outbreaks, there are no licensed vaccines or treatments for MERS. Since the virus was first identified in Saudi Arabia in 2012, the World Health Organization reports almost 1,900 MERS infections and nearly 700 deaths worldwide. Twenty seven countries have reported cases, including Korea where an outbreak in the summer of 2015 resulted in 186 cases and 38 deaths. While a SARS epidemic in 2003 killed 10% of those infected, MERS has killed about 36% of people who contracted this communicable virus.

About IVI

The International Vaccine Institute (IVI) is the world’s only international organization devoted exclusively to developing and introducing new and improved vaccines to protect the world’s poorest people, especially children in developing countries. Established in 1997, IVI operates as an independent international organization under a treaty signed by 35 countries and the World Health Organization. The Institute conducts research in more than 20 countries of Asia, Africa and Latin America on vaccines against enteric and diarrheal infections, Japanese encephalitis, MERS, and dengue fever, and develops new and improved vaccines at its headquarters in Seoul, Republic of Korea.

About GeneOne Life Science, Inc.

GeneOne is an international company focused on finding gene-based solutions to clinical disease. GeneOne is at the forefront of DNA vaccine and DNA-based therapeutic development. GeneOne is currently spearheading clinical trials of vaccines for the Zika virus, MERS-CoV, Ebola and other infectious diseases. GeneOne has a rich pipeline of products targeting multiple cancers and diseases of man. GeneOne’s wholly-owned subsidiary VGXI, Inc. (www.vgxii.com) has 15 years of experience in the manufacture of DNA plasmid vaccines and therapeutics and has the distinction of making vaccines for Zika, MERS, and Ebola for use in human clinical trials. GeneOne is headquartered in Seoul, South Korea.

About Inovio Pharmaceuticals, Inc.

Inovio is taking immunotherapy to the next level in the fight against cancer and infectious diseases. We are the only immunotherapy company that has reported generating T cells in vivo in high quantity that are fully functional and whose killing capacity correlates with relevant clinical outcomes with a favorable safety profile. With an expanding portfolio of immune therapies, the company is advancing a growing preclinical and clinical stage product pipeline. Partners and collaborators include MedImmune, The Wistar Institute, University of Pennsylvania, DARPA, GeneOne Life Science, Plumbline Life Sciences, Drexel University, NIH, HIV Vaccines Trial Network, National Cancer Institute, U.S. Military HIV Research Program, and Laval University.

For more information, please visit www.inovio.com

This press release contains certain forward-looking statements relating to our business, including our plans to develop electroporation-based drug and gene delivery technologies and DNA vaccines, our expectations regarding our research and development programs and our capital resources. Actual events or results may differ from the expectations set forth herein as a result of a number of factors, including uncertainties inherent in pre-clinical studies, clinical trials and product development programs, including the MERS vaccine GLS-5300, the availability of funding to support continuing research and studies in an effort to prove safety and efficacy of electroporation technology as a delivery mechanism or develop viable DNA vaccines, our ability to support our broad pipeline of SynCon® active immunotherapy and vaccine products, the ability of our collaborators to attain development and commercial milestones for products we license and product sales that will enable us to receive future payments and royalties, the adequacy of our capital resources, the availability or potential availability of alternative therapies or treatments for the conditions targeted by the company or its collaborators, including alternatives that may be more efficacious or cost effective than any therapy or treatment that the company and its collaborators hope to develop, issues involving product liability, issues involving patents and whether they or licenses to them will provide the company with meaningful protection from others using the covered technologies, whether such proprietary rights are enforceable or defensible or infringe or allegedly infringe on rights of others or can withstand claims of invalidity and whether the company can finance or devote other significant resources that may be necessary to prosecute, protect or defend them, the level of corporate expenditures, assessments of the company’s technology by potential corporate or other partners or collaborators, capital market conditions, the impact of government healthcare proposals and other factors set forth in our Annual Report on Form 10-K for the year ended December 31, 2015, our Form 10-Q for the quarter ended September 30, 2016, and other regulatory filings from time to time. There can be no assurance that any product in Inovio’s pipeline will be successfully developed or manufactured, that final results of clinical studies will be supportive of regulatory approvals required to market licensed products, or that any of the forward-looking information provided herein will be proven accurate.

CONTACT:
Bernie Hertel
+1 858 410 3101
bhertel@inovio.com


Kootenay Silver update on drilling at La Cigarra, Mexico.

Kootenay Silver Inc. {TSX.V: KTN} is pleased to report 6 additional core drill holes have been completed and submitted for assaying, with the core drill rig collared on the 7th hole within the La Soledad Zone, located approximately 1,000 meters south of the Company’s established La Cigarra silver resource in Chihuahua State, Mexico.

 

VANCOUVER, Dec. 7, 2016  – Kootenay Silver Inc. {TSX.V: KTN} is pleased to report 6 additional core drill holes have been completed and submitted for assaying, with the core drill rig collared on the 7th hole within the La Soledad Zone, located approximately 1,000 meters south of the Company’s established La Cigarra silver resource in Chihuahua State, Mexico.

 

Drilling on La Soledad is part of a current 3,000 meter, multi-phase discovery and resource expansion program underway to assess and evaluate several high priority targets that have been identified proximal to the La Cigarra deposit with the potential to add near surface silver resources to the project. The Company drilled the first 11 holes of the program on La Cigarra’s adjoining RAM structure resulting in an entirely new silver discovery (see news release dated November 23, 2016), within a large structurally controlled anomalous silver trend measuring 3.8 kilometers in length. Combined with the 5 holes drilled on the La Soledad structure, the Company reports it has completed a total of 16 holes to date on the program.

 

The La Soledad structure is contained within the southern extension of the main La Cigarra mineralized system that currently measures over 6.5 kilometers in length and remains open to the north and south. A comprehensive ground exploration and reconnaissance program recently conducted by Kootenay on La Soledad confirmed mineralization along the structure occurs as quartz vein breccias up to 8 meters in width with peripheral veins and stockworks in a 60 to 80 meter wide zone. Previous rock and chip sampling taken by both Northair Silver and Kootenay returned high-grade silver values of 582, 458, 323, 278, 277gpt. Kootenay’s technical team report the mineralized quartz breccias share similar textural affinities to the major Veta Colorada Mine located to the east of the La Cigarra Property (immediately north of the City of Parral) and to the San Francisco Del Oro and Santa Barbara veins being actively mined immediately south of La Cigarra. To view maps of the La Soledad Structure highlighting the silver in rock sampling program click on the following links: La Soledad Silver in Rock Sampling Plan; La Soledad Silver in Rock Sampling Image.

 

The Soledad Zone is one of 8 prospective targets that have been identified proximal to the La Cigarra deposit with the potential to add near surface silver resources to the project.

 

In total, the Company completed an additional 1,000 meters in drilling in the 5 diamond drill holes on La Soledad structure. Results from Phase I drilling on the La Soledad will be announced as soon as assays from the program are compiled and interpreted by the Company.

 

Drilling Notes

The current 16 drill holes are the first phase of a planned ongoing, multi-phase drilling program that will be conducted on the La Cigarra project over the next 12 to 18 months. Follow up drilling of the RAM and the La Soledad structures is expected to commence in the early part of the New Year and will form part of a larger strategy to test additional undrilled targets and the extensions of the La Cigarra Deposit itself.

 

Once the current 3,000 meter drill program is complete and results of re-logging and detailed mapping of the deposit are interpreted, the details and dates of the anticipated follow up programs will be finalized and announced in a future news release.

 

Sampling and QA/QC

All technical information for the La Cigarra exploration program is obtained and reported under a formal quality assurance and quality control (“QA/QC”) program. Samples are taken under the direction of qualified geologists and stored in sealed bags. Samples are delivered by the Company via courier to ALS Minerals (“ALS”) in Chihuahua. The samples are dried, crushed and pulverized with the pulps being sent airfreight for analysis by ALS in Vancouver B.C. Systematic assaying of standards is performed for precision and accuracy. Analysis for silver, zinc, lead and copper and related trace elements was done by ICP four acid digestion, with gold analysis by 30 gram fire assay with an AA finish.

 

Qualified Persons

The Kootenay technical information in this news release has been prepared in accordance with the Canadian regulatory requirements set out in National Instrument 43-101 (Standards of Disclosure for Mineral Projects) and reviewed on behalf Kootenay by James McDonald, P.Geo, President, CEO & Director for Kootenay, a Qualified Person.

 

About Kootenay Silver Inc.

Kootenay Silver Inc. is an exploration company actively engaged in the discovery and development of mineral projects in the Sierra Madre Region of Mexico and in British Columbia, Canada. The Company’s top priorities are the advancement of the La Cigarra silver project and the Promontorio Mineral Belt, in Chihuahua, Mexico and Sonora, Mexico, respectively.

 

The La Cigarra property is 26 kilometers from the historic mining city of Parral and boasts nearby power, good road access, gentle topography, and established infrastructure. La Cigarra currently hosts a resource estimate of 18.54 million tonnes containing 51.47 million ounces of silver in the Measured & Indicated categories grading 86.3 gpt silver and 4.45 million tonnes containing 11.46 million ounces of silver in the Inferred category grading 80 gpt silver.

 

The mineralized system at La Cigarra has been traced over 6.5 kilometers and is defined at surface as a silver soil anomaly and by numerous historic mine workings. The La Cigarra silver deposit is open along strike and at depth and is approximately 25 kilometers north, and along strike, of Grupo Mexico’s Santa Barbara mine and Minera Frisco’s San Francisco del Oro mine. The Promontorio Mineral Belt includes the Company’s La Negra high-grade silver discovery and its Promontorio Silver Resource. The Promontorio Mineral Belt is under option to Pan American Silver whereby they can earn a 75% interest in the project with US$16 million of expenditures and payments with Kootenay retaining a 25% carried to production interest (see news release February 16 and March 4, 2016). The Promontorio Silver Resource currently hosts a resource estimate of 44.5 million tonnes containing 92 million ounces of silver equivalent in the Measured & Indicated categories grading 64.3 gpt silver equivalent and 14.6 million tonnes containing 24.3 million ounces of silver equivalent in the Inferred category grading 52 gpt silver equivalent. The Company’s core objective is to create value by acquiring silver resources through discovery and acquisition and testing those resources with the ultimate goal of developing them into silver production if they are proven to be economically viable.

 

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS:

 

The information in this news release has been prepared as at December 7, 2016. Certain statements in this news release, referred to herein as “forward-looking statements”, constitute “forward-looking statements” under the provisions of Canadian provincial securities laws. These statements can be identified by the use of words such as “expected”, “may”, “will” or similar terms.

 

Forward-looking statements are necessarily based upon a number of factors and assumptions that, while considered reasonable by Kootenay as of the date of such statements, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Many factors, known and unknown, could cause actual results to be materially different from those expressed or implied by such forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as otherwise required by law, Kootenay expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements to reflect any change in Kootenay’s expectations or any change in events, conditions or circumstances on which any such statement is based.

 

Cautionary Note to US Investors: This news release may contain information about adjacent properties on which we have no right to explore or mine. We advise U.S. investors that the SEC’s mining guidelines strictly prohibit information of this type in documents filed with the SEC. U.S. investors are cautioned that mineral deposits on adjacent properties are not indicative of mineral deposits on our properties. This news release may contain forward-looking statements including but not limited to comments regarding the timing and content of upcoming work programs, geological interpretations, receipt of property titles, potential mineral recovery processes, etc. Forward-looking statements address future events and conditions and therefore involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated in such statements.

 

This press release uses the terms “Measured”, “Indicated”, and “Inferred” resources. United States investors are advised that while such terms are recognized and required by Canadian regulations, the United States Securities and Exchange Commission does not recognize them. “Inferred Mineral Resources” have a great amount of uncertainty as to their existence, and as to their economic and legal feasibility. It cannot be assumed that all or any part of an Inferred Mineral Resource will ever be upgraded to a higher category. Under Canadian rules, estimates of Inferred Mineral Resources may not form the basis of feasibility or other economic studies. United States investors are cautioned not to assume that all or any part of Measured or Indicated Mineral Resources will ever be converted into Mineral Reserves. United States investors are also cautioned not to assume that all or any part of a Mineral Resource is economically or legally mineable.

 

SOURCE Kootenay Silver Inc.

James McDonald, CEO and President



Scorpio Gold Announces update to court proceedings re Mineral Ridge LLC

Scorpio Gold Corp. {TSX.V: SGN} announces an update to the court proceedings involving its 70% indirectly owned subsidiary Mineral Ridge LLC, the operator of the Company’s Mineral Ridge gold operation.

 

 

Scorpio Gold Announces Update to Court Proceedings Relating to a Subsidiary
    Vancouver, December 8, 2016 – Scorpio Gold Corp. {TSX.V: SGN} announces an update to the court proceedings involving its 70% indirectly owned subsidiary Mineral Ridge LLC, the operator of the Company’s Mineral Ridge gold operation.

    On August 3, 2016, the Second Judicial District Court of Washoe County, Nevada issued an oral ruling for summary judgment awarding a drilling company, National EWP, Inc. (“National”), US$2.3 million in its lawsuit against MRG. The dispute centers on a 2012 contract in which National agreed to drill a water production well for the Mineral Ridge mine at an original contract price of US$1.145 million.

    National was ultimately paid more than US$1.2 million based on the contract and three approved change orders. At the conclusion of drilling, National sent a letter requesting additional compensation for the well and proposing that MRG pay US$2.3 million for the well. The District Court concluded that the letter constituted a change order request which, based on the Court’s interpretation of Nevada’s Prompt Payment Act, automatically became part of the contract because, the Court concluded, MRG’s responses to the request were insufficient to reject the request. A formal judgment was entered by the Court on September 22, 2016.

    In October 2016, the Company filed a motion to alter, vacate or amend the judgment. On November 29, 2016, the Court issued a Corrected Order, correcting a scrivener’s error in its earlier judgment. And on December 2, 2016, the Court formally denied the Company’s motion to alter, vacate or amend the judgment.

    The Company and its legal advisors still strongly disagree with both the Court’s legal conclusions and its factual findings. The Company has, accordingly, made the decision to seek to stay execution of the judgment pending an appeal of the judgment to the Supreme Court of Nevada. The Company’s litigation counsel believes that the Company has good grounds to appeal the judgment.

    About Scorpio Gold

    Scorpio Gold holds a 70% interest in the Mineral Ridge gold mining operation located in Esmeralda County, Nevada with joint venture partner Elevon, LLC (30%). Mineral Ridge is currently in production as a conventional open pit mining and heap leach operation.

    The Mineral Ridge property is host to multiple gold-bearing structures, veins and lenses at exploration, development and production stages. Scorpio Gold also holds a 100% interest in the advanced exploration-stage Goldwedge property in Manhattan, Nevada, with a fully permitted underground mine and 400 ton per day mill facility. The Goldwedge mill facility has been placed on a care and maintenance basis and can be restarted immediately when needed.

    ON BEHALF OF THE BOARD
    SCORPIO GOLD CORPORATION

    Brian Lock,
    Interim CEO

    For further information contact:
    Chris Zerga, President



    Churchill Mining loses ICSID case v the Republic of Indonesia

    Churchill Mining {AIM: CHL} have been informed by the ICSID based in Washington that they have lost the forgery case v the Republic of Indonesia in respect of their mining exploration licences for thermal coal, previously issued to an associate company.

     

    Churchill lose in forgery case v ROI, where to now for the company?

     

    Churchill Mining are an Australian based AIM listed company, engaged in the exploration and development of a thermal coal property in East Katai, located in East Kalimantan, Indonesia.

     

    In 2011 their exploitation licences for East Katai were discovered to hold over 3.2 billion tons of thermal coal, with a value at the time of over $3 billion. At that point you had a junior miner listed on AIM in possession of billions of dollars worth of resources,worth many multiples of their market cap, which was a huge success story, and a rare one for the AIM mining sector.

     

    At that point you had to fear the green eyed monster didn’t arrive to try and plunder the spoils that had not been previously thought to exist, but unfortunately it did. The ROI took back the licences citing such issues as mining in forestry protected areas, and forged licences. CHL were not mining at all, just exploring, and the licences were held by their local partner, Ridlatama.

     

    Ridlatama, had possession of 34 licences that the tribunal found to be “forged”, and therefore not valid. The Republic of Indonesia therefore cancelled the licences and withdrew CHL’s licence to develop and mine their discovery.

     

    Churchill took the ROI to the International Centre for settlement of Investment Disputes (ICSID), in Washington D.C. in the hope that they would be handed back the licences.

     

    Their case looked to be strong, there weren’t any problems before the valuable resources was discovered, so you hoped the tribunal would find in their favour.

     

    The ROI made a statement that the licences were forged, and so the tribunal considered evidence from both sides, with the ROI failing to produce some vital documents and a key witness, yet somewhat surprisingly ICSID decided they were forged, and found against Churchill, awarding costs of $9 million to the ROI in the process.

     

    CHL now have to consider whether to appeal and request a stay of the costs, or accept defeat, and presumably go into administration, as the $9 million cost award greatly exceeds their roughly $1 million in treasury, and one cannot see them being able to raise money to pay the ROI’s costs in a losing court case with no assets at all!

     

    This is a very sad case, following hard on the heels of Oxus Gold, another tribunal decision that looks suspect when the available evidence is perused.

     

    As an investor, all you can do is hope that the jurisdiction your company is located in is an honest and decent one, and respects international norms of governance. In this respect, maybe UK investors won’t be rushing to invest in companies located in either Indonesia nor Uzbekistan (Oxus) anytime soon?

     

    Clearly we only hear the side of the story in our media, in respect of our company, but the recent verdicts of the ICSID look possibly political rather then just, and one can only imagine the politics involved in the background if that is the case!

     

    Caveat emptor seems very appropriate in the more exotic countries mining companies work in,and for that reason I normally restrict myself to North, Central, and South America, select African countries, and Australia.

     

     

     

     

     



    Cartier Launches Drill Program on Cadillac Extension Property

    Cartier Resources Inc. {TSX-V : ECR} announced that it has commenced a diamond drill program on its Cadillac Extension property, situated 120 kilometers east of Senneterre. The program, for a total of 3 410 meters will test the depth and lateral potential of the Cu-Zn-Ag-Au Langlade deposit,

     

     

    Cartier Launches Drill Program on Cadillac Extension Property

     

    Val-d’Or, December 8th, 2016 –Cartier Resources Inc. {TSX-V : ECR} announces that it has commenced a diamond drill program on its Cadillac Extension property, situated 120 kilometers east of Senneterre. The program, for a total of 3 410 meters will test the depth and lateral potential of the Cu-Zn-Ag-Au Langlade deposit, where new OreVision IP anomalies were identified in the 2016 survey.

     

    The OreVision survey (deep IP) was a tipping point for the project. The survey was instrumental in reorienting the geological modelling of the project and drill targeting. The new anomalies are located in an area that has not been tested in the past. The geophysical signatures of the anomalies are identical to that of the Langlade deposit and stretch over 1.5 kilometers to the east.

     

    Previous, channel sampling of the massive sulphide Langlade deposit returned results grading up to 3.17% Cu, 10.11% Zn, 59.5 g/t Ag over 3.0 meters and 1.07% Cu, 1.19% Zn and 34.0 g/t Ag over 54.0 meters, and diamond drilling returned intersections grading up to 5.50% Cu, 9.30% Zn and 186.0 g/t Ag over 1.0 meters included within a broader interval grading 0.62% Cu, 0.73% Zn and 40.8 g/t Ag over 49.6 meters.

     

    “This drill program aims at discovering new massive sulphide deposits similar to Langlade where geophysics indicate the potential for a much larger volume of mineralization” commented Philippe Cloutier, President and CEO.

     

    Grant of Stock Options:

    The Board of Directors also announces that the Board of Directors of the company authorised, on December 8, 2016, the grant of 1,000,000 stock options to directors, officers and one employee of the Company. Pursuant to its stock option plan each option entitles the grantee the right to purchase a common share of the company’s stock at a price of $0.18 until December 7, 2021.

     

    Quality Assurance / Quality Control

    The scientific and/or technical information presented in this press release has been reviewed and approved by Mr. Gaétan Lavallière, P. Geo., Ph. D., and Vice President for Cartier. Mr. Lavallière is a qualified person as defined by National Instrument 43-101.

    -30-

    For more information, please contact:

    Philippe Cloutier, P.Geo.

    President and CEO

    +1 819 856 0512



    Condor Gold resolves NSR royalty dispute with B2Gold and Royal Gold

    Condor Gold {AIM: CNR}, the Nicaraguan based, AIM-listed gold exploration and development company, announced it has reached terms of a settlement with B2Gold Corporation {TSX: BTO} and Royal Gold, Inc.) {Nasdaq: RGLD}.

    This resolution solves an NSR royalty dispute and will allow La India project to progress through financing.

    Condor Gold {AIM: CNR}, the AIM-listed gold exploration company, is pleased to announce it has reached terms of a settlement with B2Gold Corp. {TSX: BTO} and Royal Gold, Inc. {Nasdaq: RGLD} over a disputed Net Smelter Return Royalty (“NSR”) over part of Condor’s flagship La India Project in Nicaragua, which hosts a high grade NI 43-101 compliant mineral resource estimate of 18.08 Mtonnes at 4.0 g/t for 2.31 Moz gold.

     

    Condor is also acquiring from B2Gold approximately 3,508 hectares of land surface rights which cover the area of the estimated mineral resource and reserves and the proposed mine site infrastructure.
    .

    Highlights:

    · Condor reaches terms of a settlement on 3% NSR with B2Gold and Royal Gold.

    · The settlement clears the way for the Project to advance towards the construction of a 1Mtpa processing plant with capacity to produce 100,000 oz gold p.a. from a single open pit.

    · Purchase from B2Gold of 3,508 hectares of land surface rights covering the mine site infrastructure and the area of the mineral resource and reserve.

    · Purchase of land surface rights from B2Gold removes an obstacle and allows the project to progress.

    · Settlement of NSR dispute and purchase of land surface rights de-risks the Project.

     

    Mark Child,Condor Gold  CEO comments:

    “I am pleased to have negotiated the terms of the settlement over a 3% NSR on part of Condor’s La India Project. It ends four years of litigation in the Canadian and Nicaragua courts with B2Gold and Royal Gold. It clears the way to progress Mina La India to construction by providing clarity to potential funding partners over a protracted NSR dispute. I am equally pleased to have acquired surface rights in respect of 3,508 hectares of land from B2Gold, which covers the area of the mine site infrastructure required for the base case 1Mtpa processing plant with capacity to produce 100,000 oz gold p.a. from a single open pit. The purchase of the land surface rights removes an obstacle to construction, not least because B2Gold undertook litigation against Condor in Nicaragua in relation to these rights. The purchase of land surface rights will facilitate negotiations with local land owners and allows the project to progress forming part of Condor’s strategy of de-risking the Project and achieving a clear path to production”.

     

    Background:

    In September 2010, Condor and B2Gold (the “Parties”) entered into a legally binding agreement to swap concessions in Nicaragua (see RNS dated 6th September 2010). In summary, Condor owned the 22sq km Cerro Quiroz Concession, which is adjacent to B2Gold’s producing mining on the La Libertad Concession and B2Gold owned the 65 sq km La India Concession. B2Gold wanted to acquire the Cerro Quiroz Concession as it increased its concession package adjacent to a producing gold mine.

    Condor had accumulated a package of four concessions that cover an area of 96 sq km around the historic gold mine on the La India Concession, had worked in the area for 4 years and was consolidating a concession package in La India Gold District. The Parties incorporated two new companies in Nicaragua. La India Gold S.A. which today is 100% owned by Condor and Cerro Quiroz S.A. which is currently 80% owned by B2Gold and 20% by Condor.

    The concession swap agreement resulted in the transfer of the La India Concession to La India Gold S.A. and the Cerro Quiroz Concession to Cerro Quiroz S.A. Condor was aware of a 3% NSR on the La India Concession at the time of the concession swap, but was not provided with a copy of the NSR agreement until almost 2 years later. After consulting legal counsel, the Board of Directors of Condor determined that the NSR was not applicable to the La India Concession. B2Gold and Royal Gold jointly sued Condor in Canada and B2Gold’s Nicaragua subsidiary company, Triton Minera S.A. filed four court cases against Condor’s local subsidiary in Nicaragua.

     

     

    The Settlement:

    Condor has entered into an Amended and Restated Net Smelter Royalty Agreement (“A&R NSR Agreement”) with International Royalty Corporation (“IRC”, a subsidiary of Royal Gold), which is conditional upon (among other things) the withdrawal of all law suits in British Columbia, Canada and Nicaragua by B2Gold and Royal Gold against Condor and its affiliate companies (the “Settlement”).

    As part of the Settlement, Condor, B2Gold and IRC will enter into an Assignment, Assumption, Novation and Consent Agreement whereby Condor will assume the liability of a 3% NSR within an Area of Interest (“AOI”) on La India Project in favour of IRC. In addition, the Settlement provides for covenants not to sue and releases to be mutually given by the parties in respect of matters relating to the Settlement. Due to a number of necessary steps required to withdraw litigation in the courts in Nicaragua and registering the security on the concessions impacted by the AOI as defined by the A&R NSR Agreement, it is expected that it may take three months for the Settlement to complete.

     

    The La India Project covers an area of 313.4 sq km and comprises ten contiguous and adjacent concessions that are 100% owned by Condor; they have been acquired over a 10 year period. The four concessions total 96 sq km (El Rodeo, El Cacao, Real De La Cruz and Santa Barbara) acquired by Condor prior the concession swap with B2Gold are excluded from the 3% NSR under the A&R NSR Agreement.

    The La India Concession and some or all of the concessions acquired by Condor after the concession swap with B2Gold will be subject to the 3% NSR: La Cuchilla, Tierra Blanca, El Zacatoso, La Mojarra with the exception of the Espinito-Mendoza concession and the area covered by the former Espinito San Pablo concession. Condor estimates a total of 138.9 sq km is within the AOI. This means approximately 90% of the Company’s current indicated and inferred resources on La India Project will be subject to a 3% NSR under the A&R NSR Agreement. An area of 174.5 sq km is excluded from the AOI and 3% NSR. See Map below:

    .

    Acquisition of 3,508 Hectares of Land Surface Rights from B2Gold and disposal of 20% Cerro Quiroz S.A.

    Following the execution and delivery of a settlement agreement to effect the Settlement, Triton Mineral S.A. will execute and deliver to Condor a document transferring certain land surface rights covering the area that hosts an estimated resource of 18.08 Mtonnes at 4.0 g/t for 2.31 Moz gold. In 1996, a predecessor company to B2Gold paid approximately US$720,000 to acquire approximately 3,508 hectares of land surface rights (known locally as possession rights) from over 120 individuals.

    As part of the Settlement, Condor will acquire these land surface rights from B2Gold in exchange for its 20% shareholding in Cerro Quiroz S.A. which owns the Cerro Quiroz Concession adjacent to La Libertad Concession. Condor is in the process of acquiring 800 to 1,000 hectares of rural land required for the mine site infrastructure to support a 1mtpa, 2,800tpd processing plant capable of processing 100,000 oz gold p.a. The area of the mine site infrastructure is within the 3,508 hectares of land surface rights. The acquisition of the land surface rights removes an obstacle and should greatly assist Condor’s land acquisition team in its negotiations with local property vendors within the 3,508 hectares area.

     

    This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

    For further information please visit www.condorgold.com

    or contact:

    Mark Child, Executive Chairman and CEO, Condor Gold plc



    Storedot “to demonstrate 5 minute car battery charge in 2017” – CEO Myersdorf

    Storedot – The Israel based hi tech battery company, that can charge a mobile phone battery in 30 seconds has now stated today that they “will demonstrate a 5 minute car battery recharge during 2017”.

     

    Storedot CEO Myersdorf conifrmed today that they will demonstrate their new molecular car battery being recharged in 5 minutes during 2017.

     

    This has huge implications for the lithium – ion battery of successful, and lithium, cobalt, and graphite suppliers will watch this new development with interest.

     

    To read the full article please CLICK HERE



    Komet Resources has a surplus of $242,370 in Q3 2016

    Komet Resources Inc. {TSX.V: KMT} has provided highlights of third quarter of 2016, which has been a very important quarter for the future development of Komet from the financial, organizational and strategic perspectives, having reached several milestones.

     

     

    Komet Resources has a surplus of $242,370 in Q3  2016

     

    2016-12-06 09:09 ET – News Release

    Mr. Andre Gagne reports
    Komet Resources Inc. {TSX.V: KMT} has provided highlights of third quarter of 2016, which has been a very important quarter for the future development of Komet from the financial, organizational and strategic perspectives, having reached several milestones.
    Strong growth in results and break-even reached
    During this period, Komet got its best gold production results to date, even though the plant is still not fully optimised. The quarterly income as of Sept. 30, 2016, exceeded $1.16-million for the first time in the company’s history and has been constantly growing at a significant pace over each quarter of 2016: $383,164 in the first quarter 2016, $658,589 in the second quarter 2016 and $1,163,938 in the third quarter 2016.

     

    The mine is cost-effective for the quarter ended Sept. 30, 2016. For the first time in the history of the company, the gold sales largely exceeded the funds invested in the project during the same period.

     

    The gold sales totalled $1,163,938 during the quarter, from which royalties amounting $87,502 were paid or are payable resulting in net income from gold sales of $1,076,436. The costs incurred at the mine during the quarter amount to $834,066, resulting in a surplus of $242,370.

     

    Most important financing of the company’s history
    In July, 2016, the company finalised a financing for a gross amount of $4,726,644, by the issuance of 13,129,567 shares at the price of 36 cents each. This issuance, with no warrants, provided the company with a net amount of $4,463,089 in view of the fees related to the issuance.

     

    This financing will allow the company to improve its financial situation, to acquire additional equipment to optimise the plant as desired in order to perform targeted exploration works on the Guiro/Diouga and the Moussala properties.

     

    Process equipment

    This quarter also marked the acquisition of the last planned equipment at the Guiro mine, including the third concentrator (Knelson KC-CD12) and the purchase of the intensive leach reactor (Concep Acacia). These two main equipment to increase recovery performance will be delivered, installed and commissioned in the first quarter of 2017.

    We seek Safe Harbor.



    Minera IRL announce new board and appoint Diego Benavides as CEO

    LIMA, PERU- – Dec. 5, 2016) – Minera IRL Ltd. {BVLAC: MIRL}, the Latin American gold mining Company, announced the appointments of Mr Diego Benavides as Director and Chief Executive Officer, Mr Michael Iannacone as Independent Director, Mr Gerardo Perez as Independent Chairman, and Mr Carlos Ruiz de Castilla as Chief Financial Officer, all effective December 5th, 2016.

     

    Minera Appoints Benavides as CEO

     

    LIMA, PERU- – Dec. 5, 2016) – Minera IRL Ltd. {BVLAC: MIRL}, the Latin American gold mining Company, is pleased to announce the appointment of Mr Diego Benavides as Director and Chief Executive Officer, Mr Michael Iannacone as Independent Director, Mr Gerardo Perez as Independent Chairman and Mr Carlos Ruiz de Castilla as Chief Financial Officer, effective December 5th, 2016.

     
    Mr Diego Benavides is a founding executive of Minera IRL and has been working full-time with the Company since its incorporation 15 years ago. He is a lawyer by training with a Masters degree in corporate leadership and business administration and with extensive experience in the Latin American mining industry and community relations.

     

    Prior to this appointment Mr Benavides held positions of Director and General Manager while incorporating several mining subsidiaries into Peru during the 1990’s. Amongst these companies were Minera Newcrest Peru SA, Minera Mount Isa Peru SA and RGC Mining Exploration. Diego Benavides is one of the pioneers in Peruvian social conflict management, having applied innovative measures including share participation partnerships and other formulas to ensure that local communities benefit from mining activities in their areas. As a result Mr Benavides was appointed an Honorary Member of the Community of Ollachea in 2007, a unique privilege.

     
    Mr Michael Iannacone has been the Chief Financial Officer of Adventus Realty Services Inc, a significant and well capitalized Canadian Real Estate Investment Trust, since March 2013. Prior to that he was CFO of various companies listed on the Toronto Stock Exchange, TSX Ventures Exchange and the AIM London Stock Exchange. Mr Iannacone has extensive experience advising companies in the industrial and resource sectors. Michael Iannacone is a former Director of the largest marine bunkering company in the Vancouver Harbour and is also currently a Director of a TSX Venture Exchange listed company. He qualified as a Chartered Accountant in 1980 while working with Coopers & Lybrand (a predecessor firm to PwC) for more than six years.

     
    Mr Gerardo Perez, Independent Chairman, was appointed Director earlier this year, and has subsequently been elected by shareholders in the recent Annual General Meeting of the Company. Mr. Perez is a lawyer and a partner in the firm of Barrios Fuentes in Lima, Peru, his areas of expertise include Administrative Law, Regulation, Infrastructure and Concessions and a wealth of management experience.

     
    Mr Perez states, “I am delighted that Diego Benavides has agreed to join Minera IRL’s Board of Directors and to assume the role of CEO. Diego brings with him a wealth of executive experience in Latin America supplemented by community relations and corporate skills which will contribute greatly to the execution of Minera IRL’s flagship gold project at Ollachea. Also, on behalf of the Board we are delighted to welcome Michael Iannacone to Minera IRL and look forward to working with him. Michael will contribute important financial and capital market skills to Minera IRL which will be positive for the development of the Company.
    “I wish to extend my sincere thanks to Frank O´Kelly for his outstanding support in the management of our Company. It has been a pleasure to have worked closely with Frank.”

     

    “Mr Carlos Ruiz de Castilla was appointed interim Chief Financial Officer for the Company in May of the current year. Previous to this appointment he held the position of Company Controller since July 2013. Carlos Ruiz has contributed outstanding work and we are pleased to appoint him as Company CFO.”

     
    The current Board will continue the process of identifying candidates to fulfill remaining Director positions as required. Until such time, the Board is confident that the Company has sufficient management resources in place in order to continue with the day-to-day business of the Company, including best efforts to achieve immediate trading in Peru and to obtain the lifting of trading restrictions in Canada.

     
    No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained in this news release.

     
    Cautionary Statement on Forward-Looking Information
    Certain information in this news release, including information about the Company’s financial or operating performance, information about the legislative regime to which the Company is subject, and other statements expressing management’s expectations or estimates of future events, performance and exploration and development programs or plans constitute “forward-looking statements”. Forward-looking statements often, but not always, are identified by words such as “seek”, “believe”, “expect”, “do not expect”, “will”, “will not”, “intend”, “estimate”, “anticipate”, “plan”, “schedule” and similar expressions of a conditional or future oriented nature identify forward-looking statements. Forward-looking statements are, necessarily, based upon a number of estimates and assumptions. While considered by management to be reasonable in the context in which they are made, forward-looking statements are inherently subject to political, legal, regulatory, business and economic risks and competitive uncertainties and contingencies. The Company cautions readers that forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause Minera IRL’s actual financial results, legislative environment, future performance and results of exploration and development programs and plans to be materially different than those expected or estimated future results, performance or achievements and that forward-looking statements are not guarantees of future performance, results or achievements.
    Forward-looking statements are made as of the date of this news release and Minera IRL assumes no obligation, except as may be required by law, to update or revise them to reflect new events or circumstances. Risks, uncertainties and contingencies and other factors that might cause actual performance to differ from forward-looking statements include, but are not limited to, any failure to obtain or complete project financing for the Ollachea Gold Project (including the Senior Debt Facility), changes in the price of precious metals and commodities, changes in the relative exchange rates of the US dollar against the Peruvian nuevo sol, interest rates, legislative, political, social or economic developments both within the countries in which the Company operates and in general, contests over title to property, the speculative nature of mineral exploration and development, operating or technical difficulties in connection with the Company’s development or exploration programs, increasing costs as a result of inflation or scarcity of human resources and input materials or equipment. Known and unknown risks inherent in the mining business include potential uncertainties related to the title of mineral claims, the accuracy of mineral reserve and resource estimates, metallurgical recoveries, capital and operating costs and the future demand for minerals. For additional information, please consult the Company’s most recently filed MD&A and Annual Information Form.
    CONTACT:
    Minera IRL Limited
    Diego Benavides Norlander
    Chief Executive Officer



    Radisson Intersects 20.2 G/T GOLD over 2.5 metres in new zone close to existing resource

    Radisson Mining Resources Inc. {TSX.V: RDS}  announced gold assay results from the first two holes of the 10,000 metres drill program underway at the O’Brien gold project along the Abitibi Greenstone Belt, Quebec.

     

     

    RADISSON INTERSECTS 20.2 G/T GOLD OVER 2.5 METRES IN A NEW ZONE LOCATED 125 METRES WEST OF CURRENT RESOURCE

     

    Rouyn-Noranda, Quebec, December 5, 2016: Radisson Mining Resources Inc. {TSX.V: RDS} is pleased to announce gold assay results from the first two holes of the 10,000 metres drill program underway at the O’Brien gold project along the Abitibi Greenstone Belt, Quebec.

     

    In 2016, mineralisation within the Piché volcanic Group was intersected on a span of 1.4 km along strike from the former O’Brien mine. To date 7 holes were completed for a total of 3,727 m since the start of the drill program announced in October. Assays pending from this additional drilling will be published in due course of business.

    • Drill hole OB-16-14 intersected 20.2 g/t Au over 2.5 m (Including 97.3 g/t Au over 0.5 m) at a depth of 355 metres in lateral extension of historic “F zone” between the old O’Brien mine and current resource. This hole intersected visible gold in the targeted structure (See Picture) and was drilled 125 metres west of 36E area and 50 metres in lateral extension of “F Zone” (See figure 1).

    • Drill hole OB-16-13 intersected 10 g/t Au over 1.5 m at a depth of 309 m in the Pontiac Group sedimentary package south of current mineral resources. This hole was completed in ore shoots extension of Kewagama area.

     

    Mario Bouchard, President and CEO commented: “The exploration drill program at the O’Brien gold project continues to deliver high-grade gold intersections in targeted areas as well as in the Pontiac Group sedimentary package which is a pleasant surprise. This supports our approach of extending the mineralization both laterally and at shallow depth to expand the resource. Moreover, 13 of the 14 holes published in 2016 have intersected targeted mineralization. Considering a hit ratio above 90% on this high-grade gold project, we are delighted with the results obtained through the drill bit in 2016. To this extent, a new drill hole targeting vertical extension, 50 m closer to surface, of newly identified ore shoot in hole OB-16-14 is planned before year-end”.

     

    Results summary at the O’Brien project

    All drill cores in this campaign are NQ in size. Analyses were completed on sawn half-cores, with the second half kept for future reference. The samples were analysed using standard fire assay procedures with AA finish at Techni-Lab Actlabs in Ste-Germaine-Boulé in Abitibi, Quebec. Samples yielding a grade higher than 5 g/t were analysed a second time by fire assay with gravimetric finish at the same laboratory. Assays containing visible gold were reanalyzed with metallic sieve procedure. Standard reference materials and blank samples were inserted prior to shipment for quality assurance and quality control (QA/QC) program.

     

    Qualified Person
    Tony Brisson, P.Geo., independent consultant, acts as a Qualified Person as defined in National Instrument 43-101 and has reviewed and approved the technical information in this press release.

     

    About Radisson Mining Resources Inc.
    Radisson is a Quebec-based mineral exploration company. The O’Brien project, cut by the regional Larder-Lake-Cadillac Fault, is Radisson’s flagship asset. The project hosts the former O’Brien Mine, considered to have been the Abitibi Greenstone Belt’s highest-grade gold producer during its production (1,197,147 metric tons at 15.25 g/t Au for 587,121 ounces of gold from 1926 to 1957; InnovExplo, April 2015).

    For more information, please visit our website at www.radissonmining.com

     

    Contact:

    Hubert Parent-Bouchard
    Corporate Development
    +1 819 763 9969

    Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
    Forward-Looking Statements: This press release may contain certain forward-looking information. All statements included herein, including the scheduled Closing date, but other than statements of historical fact, is forward-looking information and such information involves various risks and uncertainties. There can be no assurance that such information will prove to be accurate, and actual results and future events could differ materially from those anticipated in such information. A description of assumptions used to develop such forward-looking information and a description of risk factors that may cause actual results to differ materially from forward-looking information can be found in Radisson’s disclosure documents on the SEDAR website at www.sedar.com.



    Inovio awarded $6.1M sub-grant to develop DNA-based monoclonal antibodies against Zika

    Inovio Pharmaceuticals, Inc. {NASDAQ: INO} announced today that it has been awarded a $6.1 million sub-grant through The Wistar Institute to develop a DNA-based monoclonal antibody designed to provide a fast-acting treatment against Zika infection and its debilitating effects.

     

    Inovio Pharmaceuticals Awarded $6.1 Million Sub-grant Through Wistar Institute to Develop DNA-based Monoclonal Antibodies Against Zika Virus

     
    Grant Provides Funding to Help Prepare New Zika Therapy for Human Trials
    Inovio Already in Two Human Trials for its Preventive Zika Vaccine.

     
    PLYMOUTH MEETING, Pa. & PHILADELPHIA, Pa. – December 1, 2016 – Inovio Pharmaceuticals, Inc. {NASDAQ: INO} announced today that it has been awarded a $6.1 million sub-grant through The Wistar Institute to develop a DNA-based monoclonal antibody designed to provide a fast-acting treatment against Zika infection and its debilitating effects.

     

    The goal of this program, which is funded by a grant to The Wistar Institute from the Bill & Melinda Gates Foundation, is for the researchers to develop a Zika dMAb® therapy ready for human clinical trials in less than two years.

     

    There is no approved therapeutic or vaccine for Zika infection, presenting a major unmet medical need given that the World Health Organization estimates that more than two billion people are directly at risk for infection. Importantly, infection with the Zika virus during pregnancy can cause a pattern of birth defects including microcephaly.

     

    This new DNA-based monoclonal antibody technology has properties that best fit a response to address a Zika outbreak in that dMAb products can be designed and manufactured expediently on a large scale using common fermentation technology, are thermal-stable, and may be used as a therapy to provide more rapid protection from or limit the spread of Zika infection. Unlike vaccines, monoclonal antibody-based therapies could provide more immediate protection but do not develop long term immune memory. An ideal approach would therefore include the administration of a dMAb product for immediate protection and a DNA vaccine to train the immune system for longer-term, persistent protection against Zika infection. Inovio’s optimized DNA-based immunotherapy platform is uniquely positioned to target both immediate therapy through delivery of dMAb products as well as long-term immunity via DNA vaccination.

     

    Dr. J. Joseph Kim, President & CEO of Inovio, said, “As the leader in DNA-based immunotherapy and vaccine products, with our lead program poised to enter phase III study in the near term, we are also excited to expand our powerful technology platform to develop these new dMAb products. We thank the Gates Foundation for their confidence in the Inovio/Wistar team to develop this new type of medicine to address an emerging infectious disease like Zika. This grant marks the fourth major grant in the past couple of years backing the development of Inovio’s dMAb technology. Past grants include two from DARPA totaling over $56 million − one for dMAb products for Ebola and one for dMAb products for universal flu and antibiotic resistant bacteria − as well as one from the NIH for dMAb products for treating HIV infection.”

     

    Dr. David B. Weiner, Wistar’s Executive Vice President, Director of its Vaccine Center, and the W. W. Smith Charitable Trust Endowed Professorship in Cancer Research, is the principal investigator of this grant. Other collaborators on the award include Humabs Biomed and GeneOne Life Sciences. Dr. Weiner said, “Our team has strong expertise in DNA immunotherapy development, design and delivery technology as well as molecular immunology (The Wistar Institute) and DNA production and clinical studies including device & delivery development (Inovio Pharmaceuticals) and DNA studies in non-human primates. Our collaborative team skillset includes monoclonal antibody discovery (Humabs) and validation, and extensive experience working with in vivo infectious disease models and challenges (Wistar & Humab). Each group will perform experiments and provide essential reagents to other groups within the consortium. The team is experienced with translation from preclinical studies to the clinic.”

     

    In support of its dMAb technology, the Inovio/Wistar team reported earlier this year that its dMAb product for another emerging infectious disease, Chikungunya (CHKV), provided durable 100% protection in mice. In this study, a single intramuscular injection of a dMAb product protected mice from a lethal dose of the virus. The protection expressed by these dMAb antibodies was very rapid, with 100% survival in mice challenged with lethal disease as early as two days after dMAb product administration. In comparison, vaccine-driven protection can take weeks to months to reach peak efficacy levels, but provides better long term protection compared to a dMAb product. This published study demonstrates that an Inovio dMAb product and DNA vaccine could be used as an ideal combination to provide both rapid short-term as well as long-term protection. Inovio is the only organization to report such results in any disease using a DNA-based monoclonal antibody, with published preclinical data in dengue and HIV as well, and is also developing dMAb products for treating MERS, influenza, MRSA, RSV, Ebola and cancers.

     

    Inovio is advancing two trials for its DNA-based Zika vaccine. It expects to have preliminary results by year end for its U.S./Canada study. In Puerto Rico, where the CDC estimates Zika will infect more than 25% of the population by year end, Inovio’s second study employs a placebo control design that may provide exploratory signals of vaccine efficacy. The company expects to meet with regulators next year to determine the most efficient path forward to develop its Zika vaccine and help mitigate this widespread Zika outbreak that has now expanded into the continental United States.

     

    About Inovio’s dMAb Technology

    Unlike conventional monoclonal technology, which involves constructing protein-based antibodies and manufacturing them in cell culture in a complex and costly process, Inovio’s patent-protected DNA-based monoclonal antibody technology encodes the DNA sequence for a specific monoclonal antibody in a highly optimized plasmid, which would be delivered directly into a subject’s arm using electroporation. Cells in the body would then produce the encoded monoclonal antibody molecules, with intended functional activity including high antigen-binding and neutralization capabilities against the targeted disease. Monoclonal antibodies offer the benefit of inducing a rapid onset of the immune response. Overall, Inovio’s dMAb technology may provide clear advantages over conventional monoclonal antibody technology, including faster development, easier product manufacturing, and more favorable pharmacokinetics. The current monoclonal antibody product market is well over $50 billion.

     

    About Inovio Pharmaceuticals, Inc.

    Inovio is taking immunotherapy to the next level in the fight against cancer and infectious diseases. We are the only immunotherapy company that has reported generating T cells in vivo in high quantity that are fully functional and whose killing capacity correlates with relevant clinical outcomes with a favorable safety profile. With an expanding portfolio of immune therapies, the company is advancing a growing pre-clinical and clinical stage product pipeline. Partners and collaborators include MedImmune, The Wistar Institute, University of Pennsylvania, DARPA, GeneOne Life Science, Plumbline Life Sciences, Drexel University, NIH, HIV Vaccines Trial Network, National Cancer Institute, U.S. Military HIV Research Program, and Laval University.

     

    For more information, visit www.inovio.com
    CONTACT:
    Bernie Hertel
    +1 858-410-3101
    bhertel@inovio.com
    This press release contains certain forward-looking statements relating to our business, including our plans to develop electroporation-based drug and gene delivery technologies and DNA vaccines, our expectations regarding our research and development programs and our capital resources. Actual events or results may differ from the expectations set forth herein as a result of a number of factors, including uncertainties inherent in pre-clinical studies, clinical trials and product development programs, including the Zika vaccine GLS-5700, the availability of funding to support continuing research and studies in an effort to prove safety and efficacy of electroporation technology as a delivery mechanism or develop viable DNA vaccines, our ability to support our broad pipeline of SynCon® active immunotherapy and vaccine products, the ability of our collaborators to attain development and commercial milestones for products we license and product sales that will enable us to receive future payments and royalties, the adequacy of our capital resources, the availability or potential availability of alternative therapies or treatments for the conditions targeted by the company or its collaborators, including alternatives that may be more efficacious or cost effective than any therapy or treatment that the company and its collaborators hope to develop, issues involving product liability, issues involving patents and whether they or licenses to them will provide the company with meaningful protection from others using the covered technologies, whether such proprietary rights are enforceable or defensible or infringe or allegedly infringe on rights of others or can withstand claims of invalidity and whether the company can finance or devote other significant resources that may be necessary to prosecute, protect or defend them, the level of corporate expenditures, assessments of the company’s technology by potential corporate or other partners or collaborators, capital market conditions, the impact of government healthcare proposals and other factors set forth in our Annual Report on Form 10-K for the year ended December 31, 2015, our Form 10-Q for the quarter ended September 30, 2016, and other regulatory filings from time to time. There can be no assurance that any product in Inovio’s pipeline will be successfully developed or manufactured, that final results of clinical studies will be supportive of regulatory approvals required to market licensed products, or that any of the forward-looking information provided herein will be proven accurate.



    Cartier completes a drill program at Chimo

    Cartier Resources {TSX.V: ECR} announced that it has completed a drill programme on the of the Chimo Mine property. Visible gold grains were observed in three (3) structures over drill core lengths ranging from 0.2 to 1.7 meters.

     

    VAL-D’OR, QUEBEC — 01/12/16 – Cartier Resources {TSX.V: ECR} announces that it has completed a drill programme on the of the Chimo Mine property. Visible gold grains were observed in three (3) structures over drill core lengths ranging from 0.2 to 1.7 meters.

     

    The programme, consisting of six drill holes for a total of 2,517 m, aimed at testing the eastern extension of the 5M zone, the main gold-bearing structure of the Chimo Mine. The Chimo Mine, situated 45 km east of Val-d’Or produced 379,012 ounces of gold (Source: MRNF, DV 85-05 to 97-01) of which two thirds were extracted from the 5M zone.

     

    The drill holes intersected the 5M zone characterised by graphite-chlorite-biotite zones and numerous smoky quartz veins and veinlets with disseminated arsenopyrite. The 5M zone is now traced up to 700 m east of the Chimo shaft and remains open at depth.

     

    In addition, to the 5M zone, several structures with gold-bearing potential (presence of smoky quartz-biotite-tourmaline veins, disseminated and semi-massive arsenopyrite-pyrrhotite) were intersected and represent extensions of other known gold-bearing zones on the project.

     

    Core mapping and sampling has been completed. Samples for the first two holes have been sent to the laboratory and assays are pending. Samples from the four remaining holes will be sent to the laboratory over the next few days.

     

    “Our first diamond drill programme on the Chimo Mine project was successful in demonstrating the continuity of the main gold-bearing 5M zone up to 700 meters east of the shaft” commented Philippe Cloutier, President and CEO, adding “as well as intersecting the 5M zone, several structures with gold-bearing potential were intersected of which three show visible gold”.

     

    Quality Assurance / Quality Control
    The scientific and/or technical information presented in this press release has been reviewed and approved by Mr. Gaetan Lavalliere, P. Geo., Ph. D., and Vice President for Cartier. Mr. Lavalliere is a qualified person as defined by National Instrument 43-101.

    Neither the TSX Venture Exchange nor its regulatory services provider accepts responsibility for the adequacy or accuracy of this press release.
    Contact:
    Cartier Resources Inc.
    Philippe Cloutier, P.Geo.
    President and CEO



    Cascadero Copper initiates a second phase hydrometallurgical test and preparation for Taron 2 drill

    Cascadero Copper {TSX.V. CCD} has initiated a second phase of hydrometallurgical testing with the University of British Columbia (UBC) in Vancouver B.C. and Bureau Veritas Minerals’ Metallurgical Division in Richmond, B.C.

     

    Cascadero Copper initiates a second phase hydrometallurgical test and preparation for Taron 2 drill program

     

     

    Cascadero Copper {TSX.V. CCD} has initiated a second phase of hydrometallurgical testing with the University of British Columbia (UBC) in Vancouver B.C. and Bureau Veritas Minerals’ Metallurgical Division in Richmond, B.C.

     

    The objective is to produce a cesium concentrate from Taron drill core (TAR-09-4). This test work will be overseen by Dr. Rod McElroy and is expected to take two-months to complete. Given the success of this testing, the reduction of mass directed into the acid leach circuit is expected to materially lower the reagent volume required for leaching and the cost of producing cesium hydroxide.

     

    Previous Metallurgical Testing
    In December 2015, Cascadero completed proof of concept testing in the processing of a sample of Taron drill core. (TAR-09-5) The objective was to produce cesium hydroxide and cesium formate.

     

    The hydrometallurgical flow sheet that resulted from the Taron core processing was developed by UBC specifically for Cascadero, which indicated that high-recoveries of cesium (91%) were possible using off-the-shelf chemicals and run-of-mine cesium mineralized material. The final products were high-purity cesium hydroxide crystals and high-purity cesium formate solution. The Company has filed a US Provisional Patent based on this flow sheet.

     

    The first phase of the UBC process treated anticipated run-of-mine material which, when scaled up to commercial production by Cascadero’s consultants, a large volume of acid was consumed, which accounted for 58% of the total reagent cost. The second phase of testing is directed at materially reducing reagent costs.

     

    Taron Drill Program
    Cascadero has applied for the necessary permit to re-habilitate access to the Taron property and prepare drill sites. This permit is expected to be in place in mid-December 2016 and the drill permit is expected by January 9TH 2017.

    The Company intends to drill 29 HQ3 core holes each to a depth of 75 metres with the objective of identifying a cesium bearing resource in the south-western part of the Taron showing. These core holes are expected to further define the extent of the cesium mineralization present in several trenches completed in this area between 2005 and 2007, and seven HQ core holes that were drilled in 2009.

     

    About Cesium
    Cesium (chemical symbol Cs) is a rare metal best known for its extreme chemical reactivity and the chemical compound cesium hydroxide forms the start point of myriad end uses. Cesium hydroxide’s principal volume application is cesium formate (CsCHO2), which is solution with a high-density and low- viscosity. It is the go to cesium compound used to control formation pressures and temperatures in drilling of deep oil wells (HPHT). Cesium formate is also the most effective drilling and completion fluid for conventional oil and gas wells.

     

    Cesium hydroxide is the substrate cesium compound that can be converted to a range of cesium salts including cesium nitrate, cesium acetate, cesium chloride among others and as such cesium hydroxide is the starting point of a global chemicals industry. As a dense medium, cesium formate is used to separate DNA and in metallurgical testing. It is also well known for medical applications and artificially produced radioactive isotopes used to treat various types of cancers.

     

    Cesium compounds and chemicals are used in photo-emissive devices, experimental magneto-hydrodynamic electricity generation, atomic clocks for telecommunications and GPS navigation systems, catalysts in plastic and other manufacturing applications, specialty glasses, ion-propulsion rocket motors, high-density alkaline batteries, coatings for solar cells and petroleum refining. Cesium and its properties are undergoing research, which is expected to discover new applications, markets and increase demand for cesium hydroxide.

     

    The technical information in this news release was reviewed and approved for distribution by David Trueman, P. Geo., Ph.D. who is the Qualified Person for the Company. This release was also reviewed and approved by Rod McElroy Ph.D., a Consultant for the Company, who is overseeing and providing guidance for the second phase Taron hydrometallurgical tests being conducted by UBC engineers and Bureau Veritas assayers and metallurgists.

    Bill McWilliam
    President
    Cascadero Copper
    Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.



    Minera IRL AGM Result, down to one director, investors reject dissolution of pre-emptive rights

    Minera IRL Ltd (BVLAC:MIRL)  announces the results of the Annual General Meeting of Shareholders held on November 30, 2016 in Vancouver, Canada.

    Mr Bavin, Mr Weyrauch and Mr Schafer withdrew their nominations to become directors, and shareholders threw out the dissolution of pre-emptive rights regarding the issuance of new shares.

    CEO Frank O’ Kelly was not elected.

    LIMA, PERU- – Nov 30, 2016) – Minera IRL Ltd {BVLAC:  MIRL}  announces the results of the Annual General Meeting of Shareholders held on November 30, 2016 in Vancouver, Canada.

    The Company put forward nine (9) resolutions to be voted on by shareholders at the AGM. The resolutions were outlined in the Management Information Circular dated 25 October 2016 that were posted to shareholders and is available on the Company’s website at www.minera-irl.com

    A brief description of the matters voted upon and the voting results of the AGM are provided in “Appendix A – Meeting Results” at the end of this press release. The total number of ordinary shares represented by shareholders present in person or by proxy at the Meeting was 75,919,070 representing 32.8% of the Company’s outstanding ordinary shares.

    Board of Directors

    Pursuant to the articles of association of the Company (the “Articles“), each of the five directors of the Company in office prior to the AGM were proposed for election/re-election at the AGM.

    1. Prior to the AGM, each of Mr Julian Bavin, Mr Derrick Weyrauch and Mr Robert Schafer withdrew their consent to stand for election/re-election and as such the resolutions relating to such directors were not put to the AGM. Accordingly, each of Mr Bavin, Mr Weyrauch and Mr Schafer are no longer directors of the Company.
    1. The resolutions to elect/re-elect each of Mr Francis O Kelly and Mr Gerardo Perez were put to the AGM.
    1. The resolution to elect Mr O Kelly was not passed and as such Mr O Kelly is no longer a director of the Company.
    1. The resolution to elect Mr Perez was passed and as such Mr Perez remains the sole director of the Company.

    Pursuant to the Articles, Mr Perez has authority to appoint further directors. The minimum number of directors with which the board can make substantive decisions is three, so Mr Perez intends to appoint an additional two or more directors as soon as practicable.

    Other resolutions

    The resolutions to accept the financial statements of the Company for the year ended December 31, 2015 and to appoint PKF Littlejohn LLP to be the auditor of the Company for next year were passed.

    The resolutions to adopt new articles of association and granting the directors the authority to allot up to 115,567,514 ordinary shares without the application of the Company’s pre-emptive rights described in Article 6.1 of the Articles did not pass, and will not be put into effect.

    No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained in this news release.



    Minera IRL Announces Positive Drilling Update Minapampa Far East, Ollachea Project, Peru

    Minera IRL Ltd.{BVLAC:M IRL} is pleased to announce the conclusion of its 2016 Minapampa Far East drill program on the down-plunge extension of the Minapampa mineralisation of its Ollachea flagship gold project in Puno, Southern Peru.

    Minera IRL Announces Positive Drilling Update Minapampa Far East, Ollachea Project, Peru

     

     

     LIMA, PERU- Nov 28, 2016) – Minera IRL Ltd.{BVLAC:M IRL} is pleased to announce the conclusion of its 2016 Minapampa Far East drill program on the down-plunge extension of the Minapampa mineralisation of its Ollachea flagship gold project in Puno, Southern Peru. The results announced today are from 2793 m (13 drill holes) of drilling conducted in 2016 and assays are currently pending from an additional 2628 m (10 drill holes) of diamond drilling at Ollachea.

    Highlights:

    • Gold grades and widths are consistent with Minapampa mineralization up-plunge.
    • The significant drill hole intercepts are:
    DDH16-T06 8 m downhole @ 3.69 g/t from 122 metres of depth,
    DDH16-T07 13 m downhole @ 6.34 g/t from 143 metres of depth,
    DDH16-T11 16 m downhole @ 4.37 g/t from 96 metres of depth,
    DDH16-T12 18 m downhole @ 4.07 g/t from 122 metres of depth,
    DDH16-T14 31 m downhole @ 2.23 g/t from 176 metres of depth,
    DDH16-T18 30 m downhole @ 2.04 g/t from 186 metres of depth,
    DDH16-T19 25 m downhole @ 2.66 g/t from 188 metres of depth.
    • Results demonstrate the continuity of the Minapampa mineralisation at depth and to the east.
    • Mineralisation remains open down-plunge.
    • The drill hole results received to date have been used to outline an exploration target in the Minapampa Far East mineralized zone of 3 to 4.5 million tonnes grading 2.5 to 4 g/t gold, (this tonnes/grade range is reported with the framework of the N.I. 43-101 Restricted Disclosure Section 2.3(2)). The potential tonnages and grades are conceptual in nature and are based on drill results that define the approximate length, thickness, depth and grade of mineralization in the Minapampa Far East mineralised zone. There has been insufficient exploration to define a mineral resource and it is uncertain if further exploration will result in the target being delineated as a mineral resource.
    • An updated resource estimate is scheduled for completion in the first half of 2017.

    Mr. Francis O’Kelly, Chairman, comments, “The conclusion of the drilling program is an important step forward to accomplish the conditions precedent for the Cofide loan. The drilling, which intersected mineralization in all 24 holes, demonstrates the extension of the mineralized zone to the East of the main orebody. Concurrent with the program was additional drilling to secure fresh sulfide samples for metallurgical testing which will be incorporated in the ongoing detailed process engineering design.”

     

    Minapampa Far East Drill Results Summary

    The following table details all mineralised intercepts from all drill hole results received since the initiation of the drill program on Aug. 11, 2016. Previously reported drill holes “DDH13-T01”, “DDH13-T03” and “DDH13-T04” are also in the Minapampa Far East zone and so are included here for completeness. Mineralised intercepts are defined as composites whose length-weighted mean grade is greater than 1 g/t gold. In one case, an intercept <1 g/t is included as it is at the projected position of the 101 Lode (drill hole “DDH16-T18”). Maximum internal dilution is 3m. Results are uncapped. True thicknesses are reported based on the interpreted local dip and dip-direction of the mineralization and the dip of the drill hole trace. No minimum thickness constraint is applied.

    Drill HoleNumber From (m) To (m) Interval (m) True Thickness(m) Gold Assay (g/t) Interpreted Lode
    DDH13-T01 162.00 163.00 1.00 0.97 8.22 101
    DDH13-T01 170.00 196.00 26.00 23.05 3.74 201
    DDH13-T03 162.00 163.00 1.00 0.13 1.51
    DDH13-T03 172.00 174.00 2.00 1.80 2.06 101
    DDH13-T03 193.00 194.00 1.00 0.13 1.03
    DDH13-T03 198.00 209.00 11.00 9.06 5.47 201
    DDH13-T03 215.00 216.00 1.00 0.13 1.19
    DDH13-T03 219.00 220.00 1.00 0.13 1.45
    DDH13-T04 105.00 106.00 1.00 0.33 6.05
    DDH13-T04 206.00 215.00 9.00 6.52 5.45 101
    DDH13-T04 244.00 248.00 4.00 3.32 1.68 201
    DDH16-T05 72.00 78.00 6.00 5.99 1.89 201
    DDH16-T05 82.00 84.00 2.00 2.00 3.14
    DDH16-T06 122.00 130.00 8.00 7.97 3.69 201
    DDH16-T06 138.00 139.00 1.00 0.50 1.02 301
    DDH16-T06 165.00 166.00 1.00 0.50 5.33
    DDH16-T07 112.00 114.00 2.00 1.37 11.82 101
    DDH16-T07 143.00 156.00 13.00 8.72 6.34 201
    DDH16-T08 123.00 124.00 1.00 0.91 1.36
    DDH16-T08 127.00 131.00 4.00 3.65 1.11 201
    DDH16-T08 146.00 147.00 1.00 0.33 2.59 301
    DDH16-T09 72.00 73.00 1.00 0.91 2.81
    DDH16-T09 83.00 86.00 3.00 2.74 1.27 201
    DDH16-T10 190.00 196.00 6.00 4.13 1.81 101
    DDH16-T10 210.00 212.00 2.00 1.38 10.30 201
    DDH16-T10 220.00 221.00 1.00 0.44 43.26 301
    DDH16-T11 96.00 112.00 16.00 13.30 4.37 201
    DDH16-T11 116.00 117.00 1.00 0.55 3.31
    DDH16-T12 67.00 68.00 1.00 0.53 1.43
    DDH16-T12 110.00 111.00 1.00 0.95 2.21 101
    DDH16-T12 122.00 140.00 18.00 14.98 4.07 201
    DDH16-T12 145.00 149.00 4.00 2.15 3.01 301
    DDH16-T13 198.00 204.00 6.00 5.28 3.47 101
    DDH16-T13 215.00 233.00 18.00 15.84 1.23 201
    DDH16-T13 251.00 252.00 1.00 0.50 1.31
    DDH16-T14 132.00 133.00 1.00 0.67 1.05 101
    DDH16-T14 176.00 207.00 31.00 20.87 2.23 201
    DDH16-T14 211.00 212.00 1.00 0.44 1.87 301
    DDH16-T17 93.00 94.00 1.00 1.00 6.55
    DDH16-T17 98.00 102.00 4.00 3.99 3.32 201
    DDH16-T18 165.00 169.00 4.00 3.32 0.17 101
    DDH16-T18 186.00 216.00 30.00 25.03 2.04 201
    DDH16-T19 169.00 170.00 1.00 0.99 1.68 101
    DDH16-T19 188.00 213.00 25.00 22.88 2.66 201
    DDH16-T15 Assay result pending
    DDH16-T16 Assay result pending
    DDH16-T20 Assay result pending
    DDH16-T21 Assay result pending
    DDH16-T22A Assay result pending
    DDH16-T23 Assay result pending
    DDH16-T24 Assay result pending
    DDH16-T25 Assay result pending
    DDH16-T26 Assay result pending
    DDH16-T27 Assay result pending

    Figure 1 displays a plan view of the project area, while Figure 2 displays a longitudinal projection of the interpreted 201 Lode, which is the dominant mineralised structure in the Minapampa Far East zone.

    To view Figure 1: Plan view showing Minapampa Far East drill hole traces and interpreted mineralisation; and Figure 2: Longitudinal Projection of Mineralised Lode 201 showing composite gold grade (g/t) and true thickness (m)

     

    Target for further exploration

    The drill hole results received to date have been used to outline an exploration target in the Minapampa Far East mineralized zone of 3 to 4.5 million tonnes grading 2.5 to 4 g/t gold, (this tonnes/grade range is reported with the framework of the N.I. 43-101 Restricted Dislosure Section 2.3(2)). The potential tonnages and grades are conceptual in nature and are based on drill results that define the approximate length, thickness, depth and grade of mineralization in the Minapampa Far East mineralized zone. There has been insufficient exploration to define a mineral resource and it is uncertain if further exploration will result in the target being delineated as a mineral resource.

     

    Updated Resource Estimate and Timing of Future Studies

    The Company will begin a resource estimate for Minapampa Far East that will include 5,421 m of drilling upon receipt of all assay results and other supporting information. This is expected to occur towards the end of December 2016. The Company anticipates disclosing the updated resource estimate and the results of an updated feasibility study in the first half of 2017.

     

    Qualified Person

    The Minapampa Far East drill program is under the supervision of Andrew Fowler, PhD, MAusIMM CP(Geo). Dr. Fowler is a full time employee of Mining Plus Peru SAC and is an independent Qualified Person (“QP”) as defined by the National Instrument 43-101. Dr. Fowler has reviewed and approved the technical content of this release.

     

    Quality Assurance – Quality Control (“QA/QC”)

    Thorough QA/QC protocols are followed on the project including insertion of duplicate, blank and standard samples in all drill holes. The half-core samples are submitted directly to Certimin Laboratories, Juliaca, Peru for preparation. Analysis is completed at Certimin’s facility in Lima, Peru. Analysis is conducted on 50 g aliquots. Analysis of Au is performed using fire assay method with atomic absorption (AA). Certimin has been servicing the Peruvian mining industry for 21 years. It participates in international proficiency testing programs such as CANMET and GEOSTATS, and develops its services with the support of the Integrated Management System for the compliance of regulatory requirements such as ISO 9001, ISO /IEC 17025, ISO 14001, and OHSAS 18001.

     

    No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained in this news release.

    Minera IRL Limited
    Carlos Ruiz de Castilla
    Interim Chief Financial Officer
    +1 778 387 5434
    Minera IRL S.A
    Diego Benavides Norlander
    President & CEO
    + 51 418 1230



    Zenyatta Starts Pilot Plant with Delivery of 10 kilograms of High-Purity Graphite

    Zenyatta Ventures Ltd. {TSX.V: ZEN}  today announced the delivery of 10 kilograms of high-purity Albany graphite to Ben-Gurion University of the Negev (‘BGU’) and Larisplast Ltd. in Israel for the start of the next phase of testing of a pilot plant scale program.

     

     

    Zenyatta Starts Pilot Plant with Delivery of 10 kilograms of High-Purity Graphite to Ben-Gurion University and Larisplast for New Concrete Admixture Containing Graphene

     

    THUNDER BAY, ON–November 23, 2016) – Zenyatta Ventures Ltd. {TSX.V: ZEN}  today announced the delivery of 10 kilograms of high-purity Albany graphite to Ben-Gurion University of the Negev (‘BGU’) and Larisplast Ltd. in Israel for the start of the next phase of testing of a pilot plant scale program.

     

    The main objective of the pilot plant in Israel is to further test a new concrete admixture containing Albany derived graphene but with a much larger volume of concrete. The scientific and engineering data obtained will yield valuable information for potentially designing a larger scale demonstration plant. Recently, BGU demonstrated that the addition of the Company’s graphene into concrete can achieve a faster curing time and a superior mechanical performance that inhibits premature failure and tolerates large forces like those produced during earthquakes or explosions. Also, this new admixture has the potential to reduce the amount of cement that will be used in construction, thereby considerably cutting carbon dioxide emissions related to its production.

     

    Importantly, work has shown Zenyatta’s Albany graphite is easily converted to graphene with significantly higher yields of graphene nano-particles than any other natural graphite types that were tested at BGU. Graphene was first produced in 2004 at the University of Manchester by Andre Geim and Konstantin Novoselov who were jointly awarded the Nobel Prize in Physics in 2010 “for groundbreaking experiments regarding the two-dimensional material graphene.” Graphene (or Carbon) is a single sheet of pure graphite that is one atom thick, flexible, transparent, light, stronger than diamonds or steel and is highly conductive. Graphene is making inroads in diverse industries, including transportation, medicine, electronics, energy, construction, defence and desalination. So far, one obstacle to its widespread use is the high manufacturing cost for high-quality graphene. A lower-cost approach is to use high-purity natural graphite, like Zenyatta’s material, as the starting point.

     

    Dr. Bharat Chahar, VP of Market Development for Zenyatta stated, “The graphene concrete application and composite material in general can potentially be a significant end use for our high-purity graphite material. Our initiative with Larisplast and BGU is an important and new target application for Albany graphite. We are very excited to start our pilot plant collaboration program with our Israeli partners while we continue to test and develop our material for Li-ion batteries, fuel cells, powder metallurgy and other applications with several global corporations.”

     

    Zenyatta, BGU and Larisplast have received grant funding from the Canada-Israel Industrial R&D Foundation under the Ontario-Israel Collaboration Program for this pilot scale test. Upon successful completion of testing, an Agreement between the Parties contemplates the formation of a new corporation (‘Newco’) jointly owned (50/50) by Zenyatta and Larisplast for the purposes of marketing this new specialized admixture product. Zenyatta would be the exclusive provider of purified graphite to Newco and any other party working with Larisplast on this technology.

     

    Cement production for the concrete industry is a significant contributor of carbon dioxide which is a major greenhouse gas. Wide-spread use of a new graphene enhanced admixture product will have the potential to reduce the amount of cement used in construction and consequently cut considerable carbon dioxide emissions. In 2015, a total of 4.1 billion tonnes of cement was produced globally (Source: USGS). Approximately 25% of this total is in the use of Ultra-High Performance Concrete and High Performance Concrete which have the same ingredients as normal concrete but with special high cost additives. The potential increase in concrete performance enhanced with graphene would allow for a better and wider range of structures such as specialized bridges, taller buildings, marine structures and construction in seismically active areas. This could represent a very large and valuable target market for Zenyatta.

     

    Larisplast is an industry leader in Israel specializing in the field of concrete admixtures. The company develops, produces, markets and distributes high quality products and materials for Israel’s concrete industry according to strict Israeli’s standards. Larisplast operates on a nationwide basis in Israel and is currently developing international markets and distribution channels.

     

    BGU is a research leader in alternative energy, robotics and nano-technology while playing a critical role in transforming Israel’s high-tech growth. Specifically, the BGU research group focuses on carbon nanotubes and graphene product derivatives for new applications. The Advanced Technologies Park (ATP), adjacent to BGU is home to many multi-national high-tech companies, such as EMC, Oracle, Hewlett Packard, and Deutsche Telekom, which are leveraging the R&D expertise of BGU mainly through B. G. Negev Technologies and Applications Ltd. (“BGN”). BGN is the technology transfer and commercialization company for development of university technologies with industry partners.

     

    BGU’s expertise in nanoscience is advancing new materials to convert light and heat into electrical energy, to produce lightweight cars and planes of unprecedented strength. Researchers are developing incredibly small transistors to power computers, membranes for desalinating water, graphene surfaces loaded with specific drugs for delivery to targeted diseased cells, graphene reinforcement in cement-based materials and hydrogen storage device as a key enabling technology for the advancement of hydrogen and fuel cell technologies.

     

    Zenyatta continues to develop its rare igneous-hosted Albany graphite deposit in Ontario, Canada. The Company’s highly crystalline graphite deposit is fluid-derived rather than the typical and abundant sedimentary flake type graphite deposits. Albany is the largest and only graphite project of its kind in the world and was discovered by Zenyatta while exploring for Copper-Nickel in 2011-12. The unusual geologic mode of formation accounts for the favourable purity, crystallinity and particle size of graphite found in the Albany deposit. Dr. Andrew Conly (Professor, Geology at Lakehead University) observed, “Evidence has shown that Zenyatta has discovered a unique sub-class of a hydrothermal graphite deposit unlike any other. Igneous breccia-hosted graphite deposits like Albany are very rare, and to the best of my knowledge, none are currently being mined or even in an advanced stage of exploration globally. The far more common flake-type (sedimentary) graphite deposits form through a completely different geological process.”

     

    The Albany graphite deposit is situated 30 km north of the Trans-Canada Highway, power line and natural gas pipeline near the communities of Constance Lake First Nation and Hearst. A rail line is located 70 km away with an all-weather road approximately 10 km from the graphite deposit. The world trend is to develop products for technological applications that need extraordinary performance using ultra-high purity graphite powder at an affordable cost. Albany graphite can be upgraded with very good crystallinity without the use of aggressive acids (hydrofluoric) or high temperature thermal treatment therefore having an environmental advantage over other types of upgraded high-purity graphite material.

     

    The outlook for the global graphite market is very promising with demand growing rapidly from new applications. It is now considered one of the more strategic elements by many leading industrial nations, particularly for its growing importance in high technology manufacturing and in the emerging “green” industries such as electric vehicle components. The application for graphitic material is constantly evolving due to its unique chemical, electrical and thermal properties. It maintains its stability and strength under temperatures in excess of 3,000°C and is very resistant to chemical corrosion. It is also one of the lightest of all reinforcing elements and has high natural lubricating abilities. Some of these key physical and chemical properties make it critical to modern industry.

     

    Mr. Aubrey Eveleigh, P.Geo., Zenyatta’s President and CEO, is the “Qualified Person” for the purposes of National Instrument 43-101 and has reviewed, prepared and supervised the preparation of the technical information contained in this news release. Information Sources: LafargeHolcim, US Geological Survey (‘USGS’), US Environmental Protection Agency, US Department of Transportation, Freedonia Group, Marca Espana, Macleans Magazine, UCLA newsroom & personal communication with engineering firms.

     

    For Further Information, visit the Company’s website at: http://www.zenyatta.ca

     

    CAUTIONARY STATEMENT: This analysis does not represent a statistically large sample size. Furthermore, these positive results do not mean that Zenyatta can extract and process Albany graphite for graphite applications on an economic basis. Without a formal independent feasibility study, there is no assurance that the operation will be economic. Zenyatta has completed a Preliminary Economic Assessment regarding the Albany Project (the ‘PEA’) in support of its development work (see Zenyatta press release of 1 June 2015). The PEA is preliminary in nature, it includes inferred mineral resources that are considered too speculative geologically to have the economic considerations applied to them that would enable them to be categorized as mineral reserves, and there is no certainty that the preliminary economic assessment will be realized. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release may contain forward looking information and Zenyatta cautions readers that forward looking information is based on certain assumptions and risk factors that could cause actual results to differ materially from the expectations of Zenyatta included in this news release. This news release includes certain “forward-looking statements”, which often, but not always, can be identified by the use of words such as “potential”, “believes”, “anticipates”, “expects”, “estimates”, “may”, “could”, “would”, “will”, or “plan”. These statements are based on information currently available to Zenyatta and Zenyatta provides no assurance that actual results will meet management’s expectations. Forward-looking statements include estimates and statements with respect to Zenyatta’s future plans, objectives or goals, to the effect that Zenyatta or management expects a stated condition or result to occur, including the expected timing for release of a pre-feasibility study, the expected uses for graphite in the future, and the future uses of the graphite from Zenyatta’s Albany deposit. Since forward-looking statements are based on assumptions and address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results relating to, among other things, results of metallurgical processing, ongoing exploration, project development, reclamation and capital costs of Zenyatta’s mineral properties, and Zenyatta’s financial condition and prospects, could differ materially from those currently anticipated in such statements for many reasons such as, but are not limited to: failure to convert estimated mineral resources to reserves; the preliminary nature of metallurgical test results; the inability to identify target markets and satisfy the product criteria for such markets; the inability to complete a prefeasibility study; the inability to enter into offtake agreements with qualified purchasers; delays in obtaining or failures to obtain required governmental, environmental or other project approvals; political risks; uncertainties relating to the availability and costs of financing needed in the future; changes in equity markets, inflation, changes in exchange rates; fluctuations in commodity prices; delays in the development of projects; capital and operating costs varying significantly from estimates and the other risks involved in the mineral exploration and development industry; and those risks set out in Zenyatta’s public documents filed on SEDAR. This list is not exhaustive of the factors that may affect any of Zenyatta’s forward-looking statements. These and other factors should be considered carefully and readers should not place undue reliance on Zenyatta’s forward-looking statements. Although Zenyatta believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zenyatta disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.

    CONTACT INFORMATION

    • Mara Strazdins, HB.Sc.   VP Corporate Communications and Investor Relations



    Inovio seek to sever Canadian reporting obligations

    Inovio Pharmaceuticals, Inc. {NASDAQ: INO} announced that further to the voluntary delisting of Genetronics Biomedical Corporation, a predecessor of the Company, from the TSE on January 17, 2003, it has applied to the B.C Securities Commission and Ontario Securities Commission  that it is no longer a reporting issuer for the purposes of B.C. and Ontario securities law.

    The outcome of this application will not affect Inovio’s listing on the NASDAQ stock exchange nor its reporting obligations with the US Securities and Exchange Commission.

    Inovio Applies to Cease Reporting to Canadian Securities Regulatory Authorities; NASDAQ Listing and US Reporting Unaffected

    PLYMOUTH MEETING, Pa. – November 25, 2016 – Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today that further to the voluntary delisting of Genetronics Biomedical Corporation, a predecessor of the Company, from the Toronto Stock Exchange on January 17, 2003, it has applied to the British Columbia Securities Commission and Ontario Securities Commission for a decision that it is no longer a reporting issuer for the purposes of British Columbia and Ontario securities law.

    The outcome of this application will not affect Inovio’s listing on the NASDAQ stock exchange nor its reporting obligations with the US Securities and Exchange Commission.

    If an order that the Company is not a reporting issuer in British Columbia and Ontario is granted by the securities regulatory authorities from such jurisdictions, the Company will no longer be a reporting issuer in any jurisdiction of Canada and will no longer be required to file financial statements and other continuous disclosure documents with Canadian securities regulatory authorities. In this regard, Canadian security holders will continue to have access to all financial statements and other continuous disclosure documents required to be filed by the Company under United States securities laws. All reports of the Company filed with the US Securities and Exchange Commission are available at www.sec.gov as well as on the Company’s website at www.inovio.com

    About Inovio Pharmaceuticals, Inc.

    Inovio is taking immunotherapy to the next level in the fight against cancer and infectious diseases. We are the only immunotherapy company that has reported generating T cells in vivo in high quantity that are fully functional and whose killing capacity correlates with relevant clinical outcomes with a favorable safety profile. With an expanding portfolio of immune therapies, the company is advancing a growing preclinical and clinical stage product pipeline. Partners and collaborators include MedImmune, The Wistar Institute, University of Pennsylvania, DARPA, GeneOne Life Science, Plumbline Life Sciences, Drexel University, NIH, HIV Vaccines Trial Network, National Cancer Institute, U.S. Military HIV Research Program, and Laval University.

    For more information, please visit www.inovio.com

    CONTACT:
    Bernie Hertel

    +1  858-410-3101
    bhertel@inovio.com

    # # # #

    This press release contains certain forward-looking statements relating to our business, including our plans to develop electroporation-based drug and gene delivery technologies and DNA vaccines, our expectations regarding our research and development programs and our capital resources. Actual events or results may differ from the expectations set forth herein as a result of a number of factors, including uncertainties inherent in pre-clinical studies, clinical trials and product development programs, the availability of funding to support continuing research and studies in an effort to prove safety and efficacy of electroporation technology as a delivery mechanism or develop viable DNA vaccines, our ability to support our broad pipeline of SynCon® active immunotherapy and vaccine products, the ability of our collaborators to attain development and commercial milestones for products we license and product sales that will enable us to receive future payments and royalties, the adequacy of our capital resources, the availability or potential availability of alternative therapies or treatments for the conditions targeted by the company or its collaborators, including alternatives that may be more efficacious or cost effective than any therapy or treatment that the company and its collaborators hope to develop, issues involving product liability, issues involving patents and whether they or licenses to them will provide the company with meaningful protection from others using the covered technologies, whether such proprietary rights are enforceable or defensible or infringe or allegedly infringe on rights of others or can withstand claims of invalidity and whether the company can finance or devote other significant resources that may be necessary to prosecute, protect or defend them, the level of corporate expenditures, assessments of the company’s technology by potential corporate or other partners or collaborators, capital market conditions, the impact of government healthcare proposals and other factors set forth in our Annual Report on Form 10-K for the year ended December 31, 2015, our Form 10-Q for the quarter ended September 30, 2016, and other regulatory filings from time to time. There can be no assurance that any product in Inovio’s pipeline will be successfully developed or manufactured, that final results of clinical studies will be supportive of regulatory approvals required to market licensed products, or that any of the forward-looking information provided herein will be proven accurate.


    Scorpio Gold Q3 2016 financial results

    Scorpio Gold {TSX.V: SGN} have reported their Q3 2016 financial results.

    9,981 ounces of gold were produced at the Mineral Ridge mine, compared to 9,497 produced during Q3 of 2015

     

    News – Thursday, November 24, 2016
    Scorpio Gold Reports Financial Results for Third Quarter of 2016

    Vancouver, November 24, 2016 – Scorpio Gold Corporation (“Scorpio Gold” or the “Company”) (TSX-V: SGN) is pleased to announce its financial results for the third quarter ended September 30, 2016 (“Q3”).

     

    This press release should be read in conjunction with the Company’s condensed interim consolidated financial statements for Q3 of 2016 and Management Discussion & Analysis for the same period, available on the Company’s website at www.scorpiogold.com and under the Company’s name on SEDAR at www.sedar.com.

     

    All monetary amounts are expressed in US dollars unless otherwise specified.

    PERFORMANCE HIGHLIGHTS:

    Q3 2016 Q3 2015 Nine Months
    2016    		 Nine Months
    2015
    $ $ $ $
    Revenue (000’s) 13,328 9,333 35,190 33,759
    Mine operating earnings (000’s) 3,177 1,766 8,109 6,239
    Net earnings (loss) (000’s) 2,331 (15,823) 4,609 (13,321)
    Basic and diluted earnings (loss) per share 0.01 (0.11) 0.02 (0.10)
    Adjusted net earnings(1) (000’s) 2,484 1,128 5,768 3,879
    Adjusted basic and diluted net earnings per share(1) 0.01 0.01 0.03 0.02
    Adjusted EBITDA(1) (000’s) 3,508 3,208 7,893 7,946
    Adjusted basic and diluted EBITDA per share(1) 0.02 0.02 0.04 0.04
    Cash flow from operating activities (000’s) 5,906 2,271 10,418 11,223
    Total cash cost per ounce of gold sold(1) 956 732 883 779
    Gold ounces sold 10,000 8,516 28,315 29,141
    Gold ounces produced 9,981 9,497 28,578 30,187

     
    Brian Lock, Interim CEO, comments: “We are very pleased to report strong financial results for Q3 and for the first nine months of 2016.

     

    These favorable financial results largely result from the sale of 17% more ounces of gold in Q3 of 2016 compared to Q3 of 2015 at a realized price which was 22% higher during Q3 of 2016 compared to Q3 of 2015.

     

    For the nine month period ended September 30, 2016, the realized gold price was 7% higher compared to same period of 2015. Production for the third quarter of 2016 remained high at 9,981 ounces of gold compared to 9,497 for Q3 of 2015.

    “With 28,578 ounces of gold produced for the nine month period ended September 30, 2016, at a total cash cost of $883 per ounce, the Company expects to be at the higher end of the 30,000-35,000 ounces of gold produced range, and in the lower end of $900-$950 for estimated total cash cost per ounce of gold sold as per the previous revised guidance for the 2016 year.”

    Highlights for the Third Quarter Ended September 30, 2016:

    • 9,981 ounces of gold produced at the Mineral Ridge mine, compared to 9,497 produced during Q3 of 2015.
    • 10,000 ounces of gold sold, compared to 8,516 ounces sold during Q3 of 2015.
    • Revenue of $13.3 million compared to $9.3 million during Q3 of 2015.
    • Total cash cost per ounce of gold sold(1) of $956 compared to $732 during Q3 of 2015.
    • Mine operating earnings of $3.2 million compared to $1.8 million during Q3 of 2015.
    • Net earnings of $2.3 million ($0.01 basic and diluted per share), compared to net loss of $ 15.8 million ($0.11 basic and diluted per share) during Q3 of 2015.
    • Adjusted net earnings(1) of $2.5 million ($0.01 basic and diluted per share) compared to $1.1 million ($0.01 basic and diluted per share) during Q3 of 2015.
    • Adjusted EBITDA(1) of $3.5 million ($0.02 basic and diluted per share) compared to $3.2 million ($0.02 basic and diluted per share) during Q3 of 2015.
    • Cash flow from operating activities of $5.9 million compared to $2.3 million during Q3 of 2015.
    • On August 10, 2016 the Company announced the resignation of Peter J. Hawley from the position of president, effective on that date, for personal reasons. Mr. Hawley also retired from the position of CEO of the Company on November 1, 2016. Mr. Hawley remains as Chairman and a Director of the Company. The Company also announced the promotion of Chris Zerga to the position of President effective August 10, 2016. Brian Lock, a current Director of the Company, was appointed as Interim CEO effective November 2, 2016.

    Highlights for the Nine Months Ended September 30, 2016

    • 28,578 ounces of gold produced at the Mineral Ridge mine, compared to 30,187 during the nine months ended September 30, 2015.
    • 28,315 ounces of gold sold, compared to 29,141 ounces sold during the nine months ended September 30, 2015.
    • Revenue of $35.2 million compared to $33.8 million during the nine months ended September 30, 2015.
    • Total cash cost per ounce of gold sold(1) of $883 compared to $779 during the nine months ended September 30, 2015.
    • Mine operating earnings of $8.1 million compared to $6.2 million during the nine months ended September 30, 2015.
    • Net earnings of $4.6 million ($0.02 basic and diluted per share) compared to net loss of $13.3 million ($0.10 basic and diluted per share) during the nine months ended September 30, 2015.
    • Adjusted net earnings(1) of $5.8 million ($0.03 basic and diluted per share) compared to $3.9 million ($0.02 basic and diluted per share) during the nine months ended September 30, 2015.
    • Adjusted EBITDA(1) of $7.9 million ($0.04 basic and diluted per share) compared to $7.9 million ($0.04 basic and diluted per share) during the nine months ended September 30, 2015.
    • Cash flow from operating activities of $10.4 million, compared to $11.2 million during the nine months ended September 30, 2015.

    (1) This is a non-IFRS measure; refer to Non-IFRS Measures section of this press release and the Company’s Management Discussion & Analysis for Q3 of 2016 for a complete definition and reconciliation to the IFRS results reported in the Company’s financial statements for Q3 of 2016.

    Non-IFRS Measures

    The discussion of financial results in this press release includes reference to Adjusted EBITDA, Total cash cost per ounce of gold sold and Adjusted Net Earnings, which are non-IFRS measures. The Company provides these measures as additional information regarding the Company’s financial results and performance. Please refer to the Company’s Management Discussion & Analysis for Q3 of 2016 for definitions of these terms and a reconciliation of these measures to reported IFRS results.

    About Scorpio Gold

    Scorpio Gold holds a 70% interest in the Mineral Ridge gold mining operation located in Esmeralda County, Nevada with joint venture partner Elevon, LLC (30%). Mineral Ridge is currently in production as a conventional open pit mining and heap leach operation. The Mineral Ridge property is host to multiple gold-bearing structures, veins and lenses at exploration, development and production stages. Scorpio Gold also holds a 100% interest in the advanced exploration-stage Goldwedge property in Manhattan, Nevada, with a fully permitted underground mine and 400 ton per day mill facility. The Goldwedge mill facility has been placed on a care and maintenance basis and can be restarted immediately when needed.

    Scorpio Gold’s Chairman, Peter J. Hawley, PGeo,, is a Qualified Person as defined by National Instrument 43-101 and has reviewed and approved the content of this release.

    ON BEHALF OF THE BOARD
    SCORPIO GOLD CORPORATION

    Brian Lock,
    Interim CEO

     



    Komet Resources to begin drilling at Guiro, Moussala

    Komet Resources Inc. {TSX.V: KMT} have announced  a series of exploration programs in Burkina Faso and Mali.

    These will result in good newsflow in the next couple of months.

     

    Komet Resources to begin drilling at Guiro, Moussala

    2016-11-25 08:40 PT – News Release

     

    Mr. Andre Gagne reports

     

    KOMET RESOURCES INC.: UPDATE ON THE GUIRO AND MOUSSALA EXPLORATION PROGRAMS

     

    Komet Resources Inc. {TSX.V: KMT} have announced  a series of exploration programs in Burkina Faso and Mali.

    Firstly, a soil geochemical sampling program consisting of 2700 one-meter deep boreholes is currently taking place on the Guiro / Diouga permit. These samples are being collected on a 100m x 100m grid and an additional series of 1300 samples is planned on a tighter grid around gold anomalous zones that will be encountered. There could be up to a total of 4000 samples collected and analyzed. The program covers an area measuring 7.5 x 3.6 km that was the subject of previous geochemical surveys (1980s and 1990s) that revealed several gold anomalous areas where no follow-up was made.

     

    Still on the Guiro / Diouga permit, an airborne geophysical survey will kick off in December 2016. A total of 5200 linear kilometers will be flown based on 150-meter line spacings using Geotech’s versatile time-domain electromagnetic (VTEM) and magnetic system (including total field and horizontal magnetic gradient). This data will be of great help in identifying geological structures with gold potential and the next priority targets.

     

    Finally, over 2000 meters of core drilling is planned at levels 3 and 4 of the Guiro mine to identify mineralized areas striking east and west of the current mine workings, as well as deeper in the mine at level 5. The results of this drilling will support current operations and allow definition of additional resources.

     

    Moussala Permit in Mali

    A drill program starting in December 2016 on the Moussala permit will consist of reverse circulation (RC) drilling on a small 25m x 50m grid, concentrated in the Dabia south zone. A total of 3280 metres is planned, consisting in 41 boreholes that will average 80 meters depth. Added to the historical results in the same area, this program will allow for the estimation of near-surface gold resources.

     

    “After seeing our last quarterly results progress dramatically, this series of exploration programs is giving a real significance to our motto: Discovering by producing!” says Andre Gagne, Komet’s President and Chief Executive Officer.

     

    We seek Safe Harbor.

     



    Range Energy receives $1.1-million loan

    Range Energy Resources Inc. {CSE: RGO} has received a loan totalling $1,102,408 from an arm’s-length party to continue to fulfill its obligations to joint venture participants so that the development of the Khalakan block in the Kurdistan region of Iraq can continue as well as provide general working capital.

     

    Range Energy receives $1.1-million loan

    2016-11-23 15:08 PT – News Release

     

    Mr. Toufic Chahine reports

     

    RANGE RECEIVES CDN$1,102,408.00 LOAN

    Range Energy Resources Inc. {CSE: RGO} has received a loan totalling $1,102,408 from an arm’s-length party to continue to fulfill its obligations to joint venture participants so that the development of the Khalakan block in the Kurdistan region of Iraq can continue as well as provide general working capital.

     

    The loan is unsecured and evidenced by a loan agreement bearing an interest of 7 per cent for the duration of the outstanding loan, calculated and payable on demand. The company may pay the loan in whole or in part, at any time without penalty.

     

    As the $1,102,408 is a loan from an insider bearing an interest of 7 per cent, the loan constitutes a related party transaction within the meaning of Multilateral Instruments 61-101 — Protection of Minority Security Holders in Special Transactions (MI 61-101). The company relied upon the applicable exemptions under MI 61-101 from the formal valuation and minority shareholder approval requirements in relation to the loan.

     

    We seek Safe Harbor.